7 results match your criteria: "555 University Av.[Affiliation]"

Deregulation of Neuro-Developmental Genes and Primary Cilium Cytoskeleton Anomalies in iPSC Retinal Sheets from Human Syndromic Ciliopathies.

Stem Cell Reports

March 2020

Stem Cell and Developmental Biology Laboratory, Hôpital Maisonneuve-Rosemont, 5415 Boul. Assomption, Montreal, QC H1T 2M4, Canada; Department of Neurosciences, University of Montreal, Montreal, QC H3C 3J7, Canada; Department of Ophthalmology, University of Montreal, Montreal, QC H3C 3J7, Canada. Electronic address:

Ciliopathies are heterogeneous genetic diseases affecting primary cilium structure and function. Meckel-Gruber (MKS) and Bardet-Biedl (BBS) syndromes are severe ciliopathies characterized by skeletal and neurodevelopment anomalies, including polydactyly, cognitive impairment, and retinal degeneration. We describe the generation and molecular characterization of human induced pluripotent stem cell (iPSC)-derived retinal sheets (RSs) from controls, and MKS (TMEM67) and BBS (BBS10) cases.

View Article and Find Full Text PDF

Three dimensional analysis of brace biomechanical efficacy for patients with AIS.

Eur Spine J

November 2013

Pediatric Orthopedic Surgery Division, Hospital for Sick Children, 555 University Av, Toronto, ON, M5G 1X8, Canada,

Purpose: Corrective three dimensional (3D) effect of different braces is debatable. We evaluated differences in in-brace radiographic correction comparing a custom thoracic-lumbo-sacral-orthosis (TLSO) (T) brace to a Chêneau type TLSO (C) brace using 3D EOS reconstruction technology. Our primary research question was the 3D effect of brace on the spine and in particularly the apical vertebra rotation (AVR).

View Article and Find Full Text PDF

Uropathogenic Escherichia coli infection: potential importance of epigenetics.

Epigenomics

April 2012

Division of Urology, Developmental & Stem Cell Biology, Hospital for Sick Children, Research Institute, Institute of Medical Sciences, University of Toronto, 555 University Av., M5G 1X8 Toronto, ON, Canada.

Patients suffering from recurrent urinary tract infections (UTIs) may be maintained on antibiotic prophylaxis, or even treated by surgery. However, there are no biological data on which to base such treatment selection for the individual patient. This highlights the need for a biological marker that might predict UTI recurrence risk.

View Article and Find Full Text PDF

Modifier gene studies to identify new therapeutic targets in cystic fibrosis.

Curr Pharm Des

June 2012

Neuroscience and Mental Health Program, The Hospital for Sick Children, 555 University Av., Toronto, ON M5G 1X8, Canada.

Since the discovery of the CFTR gene mutations which cause cystic fibrosis (CF) in 1989 the average life expectancy of CF patients has almost doubled and now exceeds 37 years. The advances in molecular diagnostics and medical treatments expanded beyond the CF patient population as some of the newest treatments are also being tested for treatment of complex diseases such as COPD and other inherited disorders. Rapid development of CF therapeutics is important for the cystic fibrosis community and is an excellent example for other nonprofit organizations, disease foundations and pharmaceutical companies alike.

View Article and Find Full Text PDF

Cell surface dynamics of CFTR: the ins and outs.

Biochim Biophys Acta

April 2007

Hospital for Sick Children Research Institutes, Cell Biology, 555 University Av., Toronto, Ontario, Canada M5G 1X8.

Ganeshan et al. (Biochem Biophys. Acta 1173 (2007) 192-200) recent study documents the effect of N-WASP inhibition and actin cytoskeleton disruption on the constitutive internalization and recycling of the cystic fibrosis transmembrane conductance regulator (CFTR) channel.

View Article and Find Full Text PDF

Intracellular routing of plasmid DNA during non-viral gene transfer.

Adv Drug Deliv Rev

April 2005

Hospital for Sick Children, Program in Cell and Lung Biology and Department of Laboratory Medicine and Pathobiology, University of Toronto, 555 University Av., Toronto, Ontario, Canada M5G 1X8.

Gene transfer using non-viral vectors is a promising approach for the safe delivery of therapeutic DNA in genetic and acquired human diseases. Whereas the lack of specific immune response favors the use of plasmid-cationic polymer complexes, the limited efficacy and short duration of transgene expression impose major hurdles in the application of non-viral gene delivery techniques. Here, we review the major cellular, metabolic and physico-chemical impediments that non-viral vectors encounter before plasmid DNA enters the nucleus.

View Article and Find Full Text PDF

Intracellular barriers to non-viral gene transfer.

Curr Gene Ther

May 2002

Hospital for Sick Children, Program in Cell and Lung Biology, Department of Laboratory Medicine and Pathobiology, University of Toronto, 555 University Av., Toronto, Ontario, Canada, M5G 1X8.

Non-viral vector mediated gene transfer, compared to viral vector mediated one, is a promising tool for the safe delivery of therapeutic DNA in genetic and acquired human diseases. Although the lack of specific immune response favor the clinical application of non-viral vectors, comprising of an expression cassette complexed to cationic liposome or cationic polymer, the limited efficacy and short duration of transgene expression impose major hurdles in the widespread application of non-viral gene therapy. The trafficking of transgene, complexed with chemical vectors, has been the subject of intensive investigations to improve our understanding of cellular and extracellular barriers impeding gene delivery.

View Article and Find Full Text PDF